Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats

Neuroscience

Volumn 75, Issue 1, 1996, Pages 43-56

  Wang, J Q ^a   McGinty, J F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

dynorphin; enkephalin; nuclear accumbens; oxotremorine; scopolamine; substance P

Indexed keywords

AMPHETAMINE; DYNORPHIN; ENKEPHALIN; MESSENGER RNA; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; OXOTREMORINE; SCOPOLAMINE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030572770     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00277-1     Document Type: Article

References (52)

1. 2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518:1990;193-198.
2. Anderson J. J., Chase T. N., Engber T. M. Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats. Brain Res. 623:1993;189-194.
3. Arnfred T., Randrup A. Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior. Acta pharmac. toxic. 26:1993;384-394.
4. 2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum. Neuroscience. 53:1993;417-424.
5. Bannon M. J., Haverstick D. M., Shibata K., Poosch M. S. Preprotachykinin gene expression in the forebrain: regulation by dopamine. Ann. N. Y. Acad. Sci. 632:1991;31-37.
6. Bannon M. J., Kelland M., Chiodo L. Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum. J. Neurochem. 52:1989;859-862.
7. Bernard V., Dumartin B., Lamy E., Bloch B. Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur. J. Neurosci. 5:1993;1218-1225.
8. Bernard V., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12:1992;3591-3600.
9. 2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 54:1990;2145-2148.
10. Blackburn J. R., Chapman C. A., Blaha C. D., Yeomans J. S. Striatal dopamine levels increase following peripheral scopolamine injections and following application of scopolamine to the tegmental pedunculopontine nucleus. Soc. Neurosci. Abstr. 20:1994;1559.
11. Bolam J. P., Wainer B. H., Smith A. D. Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi impregnation and electron microscopy. Neuroscience. 12:1984;711-718.
12. Butkerait P., Friedman E. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390. Eur. J. Pharmac. 148:1988;269-272.
13. Bymaster F. P., Heath I., Hendrix J. C., Shannon H. E. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J. Pharmac. exp. Ther. 267:1993;16-24.
14. Chou H., Ogawa N., Asanuma M., Hirata H., Mori A. Muscarinic cholinergic receptor-mediated modulation of striatal c-fos mRNA expression induced by levodopa in rat brain. J. neural Transm. 90:1992;171-181.
15. 2 dopamine receptors and the regulation of striatal acetylcholine release in vivo. Prog. Brain Res. 98:1993;201-207.
16. Damsma G., Robertson G. S., Tham C. S., Fibiger H. C. Dopaminergic regulation of striatal cholinergic release: importance of D1 and N-methyl-D-aspartate receptors. J. Pharmac. exp. Ther. 259:1991;1064-1072.
17. 1 receptor stimulation increases striatal acetylcholine release in the rat. Eur. J. Pharmac. 186:1990;335-338.
18. Daunais J. B., McGinty J. F. Muscarinic receptors modulate apomorphine induction of dynorphin in striatal patch neurons. Soc. Neurosci. Abstr. 16:1990;1233.
19. Dewey S. L., Smith G. S., Logan J., Brodie J. D., Simkowitz P., MacGregor R. R., Fowler J. S., Volkow N. D., Wolf A. P. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal and human subjects. Proc. natn. Acad. Sci. U.S.A. 90:1993;11816.
20. Dokas L. A., Ting S. M. A comparison of the regulatory properties of striatal and cortical adenylate cyclase. Neurobiol. Aging. 14:1993;65-72.
21. Elde R., Schalling M., Ceddatelli S., Nakanishi S., Hokfelt T. Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors. Neurosci. Lett. 120:1990;134-138.
22. Florin S. M., Kuczenski R., Segal D. S. Amphetamine-induced changes in behavior and caudate extracellular acetylcholine. Brain Res. 581:1992;53-55.
23. Gerfen C. R. Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556:1991;165-170.
24. Guennoun R., Bloch B. Ontogeny of D1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study. Molec. Brain Res. 12:1992;131-139.
25. Guo N., Robertson G. S., Fibiger H. C. Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588:1992;164-167.
26. Hagan J. J., Tonnaer J. A. D. M., Rijk H., Broekkamp C. L. E., van Delft A. M. L. Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity. Brain Res. 410:1987;69-73.
27. Haverstick D., Rubenstein A., Bannon M. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors. J. Pharmac. exp. Ther. 248:1989;858-862.
28. Hong J. S., Yang H. T. T., Gillin J. C., Costa E. Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons. Adv. biochem. Psychopharmac. 24:1980;223-232.
29. Hulme E. C., Birdsall N. J. M., Buckley N. J. Muscarinic receptor subtypes. A. Rev. Pharmac. Toxic. 30:1990;633-673.
30. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. natn. Acad. Sci. U.S.A. 87:1990;230-234.
31. 2 dopamine receptor gene expressed by cholinergic neurons in the rat striatum. Neurosci. Lett. 117:1990;248-252.
32. Lindefors N., Hurd Y. L., O'Connor W. T., Brene S., Persson H., Ungerstedt U. Amphetamine regulation of acetylcholine and γ-aminobytyric acid in nucleus accumbens. Neuroscience. 48:1992;439-448.
33. Lomax P. Drugs and body temperature. Int. Rev. Neurobiol. 12:1970;1-43.
34. Lucas L. R., Harlan R. E. Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum. Molec. Brain Res. 30:1995;181-195.
35. Mandel R. J., Leanza G., Nilsson O. G., Rosengren E. Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Brain Res. 653:1994;57-65.
36. Mavridis M., Rogard M., Besson M. J. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane®) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression. Neuroscience. 66:1995;37-53.
37. 2 mediated responses. Neuroscience. 53:1993;673-678.
38. Morelli M., Pinna A., Fenu S., Carta A., Cozzolino A., Di Chiara G. Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats. Synapse. 18:1994;288-293.
39. Phelps P. E., Houser C. R., Vaughn J. E. Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses. J. comp. Neurol. 238:1985;286-307.
40. 2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Molec. Brain Res. 13:1992;35-41.
41. Shannon H. E., Peters S. C. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice. J. Pharmac. exp. Ther. 255:1990;549-553.
42. Smith A. J. W., McGinty J. F. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Molec. Brain Res. 21:1994;359-362.
43. Steinberg R., Rodier D., Souilhac J., Bougault I., Emonds-Alt X., Soubrie P., Fur G. L. Pharmacological charaterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J. Neurochem. 65:1995;2543-2548.
44. Surmeier D. J., Reiner A., Levine M. S., Ariano M. A. Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16:1994;299-305.
45. Wang J. Q., McGinty J. F. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J. Pharmac. exp. Ther. 273:1995;909-917.
46. 2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse. 22:1996;114-122.
47. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience. 72:1996;601-616.
48. Wang J. Q. and McGinty J. F. (1996) Glutamatergic and cholinergic regulation of immediate early gene and neuropeptide gene expression in the striatum. In Pharmacological Regulation of Gene Expression in the CNS (ed. Merchant K. M.). CRC Press, Boca Raton, FL (in press).
49. Wang J. Q., Smith A. J. W., McGinty J. F. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin mRNA expression in rat forebrain. Neuroscience. 68:1995;83-95.
50. Weiner D. M., Levey A., Brann M. R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. natn. Acad. Sci. U.S.A. 87:1990;7050-7054.
51. Young W. S. III, Bonner T. I., Brann M. R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. natn. Acad. Sci. U.S.A. 83:1986;9827-9831.
52. Young W. S., Mezey E., Siegel R. E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70:1986;198-203.